CompletedNot Applicable

Assessment of Maternal and Fetal Serum Biomarkers in Women With Pre-eclampsia

Iraq204 participantsStarted 2024-12-13

Plain-language summary

The findings of markers of placental dysfunction in women with preeclampsia may suggest that these biomarkers may be useful tools for early detection of preeclampsia

Who can participate

Age range

18 Years – 45 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age group 18-45 years * Gestational age of 26-41 weeks at the time of diagnosis for preeclampsia * Delivered vaginally or abdominally * Being of any parity (para 1 and more) * Pregnancy being singleton or multiple pregnancies * Willingness to provide informed consent Exclusion Criteria: * Pregnant woman having chronic hypertension * Having Diabetes mellitus * The lady on medications that can affect inflammatory markers or blood pressure * Pregnant with fetal anomalies * Refused to involve in the research

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

To compare the levels of maternal and fetal serum soluble Fms-like tyrosine kinase-1 (sFlt-1), seromucoid, and protein-bound hexose between women with pre-eclampsia and a control group of healthy pregnant women.

Timeframe: one hour

Trial details

NCT IDNCT06712550

SponsorSHAHLA KAREEM ALALAF

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-07-03

View on ClinicalTrials.gov More Inflammatory Markers trials